Report Detail

In this emerging in the form of cooperation, biological medicine industry further extended to the biological agents in the form of outsourcing cooperation contract development and manufacturing organization (CDMO) mode, the CDMO from preclinical studies and clinical trials to commercial production stage and the enterprise research and development, procurement, production, such as depth of the whole supply chain system docking, provide enterprises with innovative technology research and development and large-scale production services, in the higher value-added technology output instead of the pure output capacity.
In 2018, the global Biologics Contract Development and Manufacturing Organization(CDMO) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Biologics Contract Development and Manufacturing Organization(CDMO) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biologics Contract Development and Manufacturing Organization(CDMO) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Lonza
Hansen
Boehringer Ingelheim BioXcellence
Thermo Fisher Scientific
Samsung BioLogics
AGC Biologics
Catalent
Wuxi Biologics

Market segment by Type, the product can be split into
Biologics Contract Development Services
Biologics Contract Manufacturing Services

Market segment by Application, split into
Big Pharma
Small Pharma
Generic Pharma
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Biologics Contract Development and Manufacturing Organization(CDMO) status, future forecast, growth opportunity, key market and key players.
To present the Biologics Contract Development and Manufacturing Organization(CDMO) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Biologics Contract Development and Manufacturing Organization(CDMO) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Biologics Contract Development Services
      • 1.4.3 Biologics Contract Manufacturing Services
    • 1.5 Market by Application
      • 1.5.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application (2019-2025)
      • 1.5.2 Big Pharma
      • 1.5.3 Small Pharma
      • 1.5.4 Generic Pharma
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Size
    • 2.2 Biologics Contract Development and Manufacturing Organization(CDMO) Growth Trends by Regions
      • 2.2.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Regions (2019-2025)
      • 2.2.2 Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by by Players
      • 3.1.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by by Players (2014-2019)
      • 3.1.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players Head office and Area Served
    • 3.3 Key Players Biologics Contract Development and Manufacturing Organization(CDMO) Product/Solution/Service
    • 3.4 Date of Enter into Biologics Contract Development and Manufacturing Organization(CDMO) Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2014-2019)
    • 4.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2014-2019)
    • 5.2 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players in North America
    • 5.3 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
    • 5.4 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application

    6 Europe

    • 6.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2014-2019)
    • 6.2 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players in Europe
    • 6.3 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
    • 6.4 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application

    7 China

    • 7.1 China Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2014-2019)
    • 7.2 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players in China
    • 7.3 China Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
    • 7.4 China Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application

    8 Japan

    • 8.1 Japan Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2014-2019)
    • 8.2 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players in Japan
    • 8.3 Japan Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
    • 8.4 Japan Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2014-2019)
    • 9.2 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players in Southeast Asia
    • 9.3 Southeast Asia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
    • 9.4 Southeast Asia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application

    10 India

    • 10.1 India Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2014-2019)
    • 10.2 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players in India
    • 10.3 India Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
    • 10.4 India Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2014-2019)
    • 11.2 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players in Central & South America
    • 11.3 Central & South America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
    • 11.4 Central & South America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application

    12 International Players Profiles

    • 12.1 Lonza
      • 12.1.1 Lonza Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
      • 12.1.4 Lonza Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2014-2019))
      • 12.1.5 Lonza Recent Development
    • 12.2 Hansen
      • 12.2.1 Hansen Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
      • 12.2.4 Hansen Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2014-2019)
      • 12.2.5 Hansen Recent Development
    • 12.3 Boehringer Ingelheim BioXcellence
      • 12.3.1 Boehringer Ingelheim BioXcellence Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
      • 12.3.4 Boehringer Ingelheim BioXcellence Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2014-2019)
      • 12.3.5 Boehringer Ingelheim BioXcellence Recent Development
    • 12.4 Thermo Fisher Scientific
      • 12.4.1 Thermo Fisher Scientific Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
      • 12.4.4 Thermo Fisher Scientific Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2014-2019)
      • 12.4.5 Thermo Fisher Scientific Recent Development
    • 12.5 Samsung BioLogics
      • 12.5.1 Samsung BioLogics Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
      • 12.5.4 Samsung BioLogics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2014-2019)
      • 12.5.5 Samsung BioLogics Recent Development
    • 12.6 AGC Biologics
      • 12.6.1 AGC Biologics Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
      • 12.6.4 AGC Biologics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2014-2019)
      • 12.6.5 AGC Biologics Recent Development
    • 12.7 Catalent
      • 12.7.1 Catalent Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
      • 12.7.4 Catalent Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2014-2019)
      • 12.7.5 Catalent Recent Development
    • 12.8 Wuxi Biologics
      • 12.8.1 Wuxi Biologics Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
      • 12.8.4 Wuxi Biologics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2014-2019)
      • 12.8.5 Wuxi Biologics Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Biologics Contract Development and Manufacturing Organization(CDMO). Industry analysis & Market Report on Biologics Contract Development and Manufacturing Organization(CDMO) is a syndicated market report, published as Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Biologics Contract Development and Manufacturing Organization(CDMO) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,077.10
      4,615.65
      6,154.20
      3,588.00
      5,382.00
      7,176.00
      605,163.00
      907,744.50
      1,210,326.00
      325,650.00
      488,475.00
      651,300.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report